Firearms - Right to Purchase, Own, Possess, and Carry
Summary
SB 994 would prohibit a person from being denied the right to purchase, own, possess, or carry a firearm solely because the person is authorized to use medical cannabis under Maryland law. The bill adds a new section to the Public Safety Article stating that medical cannabis authorization, by itself, may not be used as the sole basis to restrict firearm rights under that title.
The measure is narrowly focused on firearm eligibility and does not change Maryland’s medical cannabis program or broader firearm laws beyond this specific protection. It would take effect October 1, 2025, and would apply to state law governing firearm purchase, ownership, possession, and carrying.
Impact
The bill would amend the Public Safety Article by adding Section 5-901, creating an explicit statutory protection for medical cannabis patients in relation to firearm rights. In practical terms, it limits state-level denial of firearm privileges when the only disqualifying factor is authorization to use medical cannabis under Title 36, Subtitle 3 of the Alcoholic Beverages and Cannabis Article. It does not appear to alter federal firearm law, background check requirements, or other existing disqualifications unrelated to medical cannabis use.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, support, or opposition in the available materials. Based on the bill text alone, the proposal appears to be framed as a targeted rights-protection measure for medical cannabis users rather than a broader firearms policy change. The absence of recorded legislative discussion makes the overall sentiment difficult to gauge from the provided record.
Contention
The main point of potential contention is the intersection of medical cannabis use and firearm regulation. Supporters would likely view the bill as preventing categorical denial of firearm rights to lawful medical cannabis patients, while opponents may raise concerns about firearm access by individuals using a substance that remains restricted under federal law. Another possible issue is that the bill only bars denial based solely on medical cannabis authorization, leaving open questions about how agencies or dealers would treat cases involving other factors or federal compliance concerns.